Hormonal Therapy: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

curprev 12:1312:13, 17 February 2023‎ Urology4all talk contribs‎ 55,182 bytes +140‎ →‎Androgens and the Prostate undo Tag: Visual edit
curprev 12:1012:10, 17 February 2023‎ Urology4all talk contribs‎ 55,042 bytes +350‎ No edit summary undo
curprev 12:0412:04, 17 February 2023‎ Urology4all talk contribs‎ 54,692 bytes −72‎ →‎Recommended Investigations Prior to ADT initiation (2021 CUA Guidelines§) undo Tag: Visual edit
curprev 12:0312:03, 17 February 2023‎ Urology4all talk contribs‎ 54,764 bytes −75‎ →‎Complications of Androgen Ablation undo Tag: Visual edit

curprev 08:5908:59, 17 December 2021‎ Urology4all talk contribs‎ 54,839 bytes +30‎ No edit summary undo
curprev 08:2108:21, 17 December 2021‎ Urology4all talk contribs‎ 54,809 bytes +54,809‎ Created page with "'''Includes 2021 CUA Guidelines on Androgen Deprivation Therapy: Adverse Events and Management Strategies'''§ == Testosterone == * '''See section in Male Reproductive Physiology Chapter Notes''' == Androgens and the Prostate == * '''The primary androgen of the prostate is dihydrotestosterone (DHT)''' * '''Testosterone is converted to DHT by 5α-reductase''' ** '''Type 1 5α-reductase is expressed primarily in the non-genital skin and liver, and to a lesser extent in..." Tag: Visual edit

Hormonal Therapy: Revision history

18 March 2024

15 March 2024

6 January 2024

17 February 2023

17 December 2021